What to Know About the New Semaglutide Pill for Obesity

This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-01-16
DOI
https://doi.org/10.1001/jama.2026.0035
Citations
2
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
65.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What to Know About the New Semaglutide Pill for Obesity

Kate Schweitzer
2 citations
JAMA
Pharmacology and Obesity Treatment
65.15
article

What to Know About the New Semaglutide Pill for Obesity

Kate Schweitzer
article en
2 citations

Abstract

This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults.

JAMAVol. 335(6)
ING Direct (US)
Zero hunger
Openalex Percentile: Top 0%
Pharmacology and Obesity Treatment
65.15
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

What to Know About the New Semaglutide Pill for Obesity — Kate Schweitzer · JAMA (2026) | TGRS Research Map | TGRS